Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Mark C. Miller currently holds 55,282 shares of Accelerate Diagnostics, Inc (AXDX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark C. Miller has been a net seller of AXDX stock. They have purchased $992.0K and sold $206.0M worth of shares.
Mark C. Miller's most recent insider trade was on Mar 7, 2023, when they sold 4,396 shares at $0.00 per share.
Mark C. Miller serves as Executive at Accelerate Diagnostics, Inc (AXDX). They have executed 263 insider transactions totaling $207.0M over their tenure at the company.
Mark C. Miller holds the position of Executive at Accelerate Diagnostics, Inc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
Mark C. Miller has shown a selling trading pattern, with $992.0K in total purchases and $206.0M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Mark C. Miller was on Apr 8, 2019, when they sold $7.6M worth of SRCL shares. This transaction involved 132,030 shares at $57.30 per share.
Mark C. Miller currently owns 55,282 shares of Accelerate Diagnostics, Inc (AXDX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Mark C. Miller's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Mark C. Miller has 263 Form 4 filings on record as an insider at Accelerate Diagnostics, Inc.
Set alerts for Mark C. Miller and 40,000+ other insiders.